Results 171 to 180 of about 8,117 (271)

Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA)

Journal of Asthma and Allergy, 2020
Reynold A Panettieri Jr,1 Tobias Welte,2 Kartik V Shenoy,3 Stephanie Korn,4 Margret Jandl,5 Edward M Kerwin,6 Rosa Feijoo,7 Peter Barker,8 Richard F Olsson,9 Ubaldo J Martin8 On behalf of the SOLANA Study Investigators1Pulmonary, Allergy and Critical ...
Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ   +9 more
doaj  

Switching Treatment from Mepolizumab to Benralizumab for Elderly Patients with Severe Eosinophilic Asthma: A Retrospective Observational Study

, 2022
Shoko Isoyama, Nobuhisa Ishikawa, Kosuke Hamai, Mirai Matsumura, Hiroki Kobayashi, Akio Nomura, Sayaka Ueno, Takuya Tanimoto, Hiroyuki Maeda, Hiroshi Iwamoto, Noboru Hattori   +10 more
openalex   +2 more sources

Development of vasculitis in a case with severe asthma treated with benralizumab and low-dose corticosteroid

, 2022
Natsuka Umezawa, Hirokazu Sasaki, Haruhiko Furusawa, Daisuke Kawata, Chiina Hata, Shinsuke Yasuda   +5 more
openalex   +1 more source

Resolution of daytime and night-time respiratory symptoms but persistent sleep apnea in severe asthma with the add-on of benralizumab

, 2022
Pasquale Tondo, Francesco Fanfulla
openalex   +2 more sources

Long-Term Real-World Outcomes of Mepolizumab and Benralizumab Among Biologic-Naive Patients With Severe Eosinophilic Asthma: Experience of 3 Years’ Therapy

, 2023
Fred Fyles, Amy Nuttall, Hannah Joplin, Hassan Burhan   +3 more
openalex   +2 more sources

Successful pregnancy in the setting of eosinophil depletion by benralizumab

The Journal of Allergy and Clinical Immunology: In Practice, 2021
Fei Li Kuang, Scott Manetz, Irina Maric, Lauren Wetzler, Amy D. Klion, Tom Brown, Elizabeth Battisto   +6 more
openaire   +3 more sources

Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trial

Allergology International
Background: Biologics are integral in the management of severe asthma. As the effectiveness of the anti-IL-5 receptor antibody benralizumab in Japan remains elusive, this study aimed to assess its real-world effectiveness in Japanese patients with severe
Katsunori Masaki, Maho Suzukawa, Hitoshi Sasano, Norihiro Harada, Yasunari Miyazaki, Hideki Katsura, Etsuko Tagaya, Junko Terada, Masayuki Hojo, Naoya Sugimoto, Hiroyuki Nagase, Yuta Kono, Hisato Hiranuma, Yasuhiro Gon, Ryo Takemura, Misato Irie, Reina Nakamura, Hiroki Kabata, Jun Miyata, Koichi Fukunaga   +19 more
doaj  

Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants

, 2023
TT Cheung, Tu H., Yen Lin Chia, Desmond YH Yap, Chi‐Ho Lee, Cecil Chi-Keung Chen, Ying Huang, Yuwen Jin, James B. Johnston, Viktoría Werkström, Yuhui Yao, Xiaoyun Ge, Wenying Zheng   +12 more
openalex   +2 more sources

Airway Occlusion Pressure Revisited. [PDF]

, 2020
Sassoon, Catherine S, Younes, Magdy
core  

Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial.

The Lancet Respiratory Medicine
Sanjay Ramakrishnan, Richard E K Russell, Hafiz R Mahmood, K. Krassowska, J. Melhorn, C. Mwasuku, I. Pavord, L. Bermejo-Sanchez, I. Howell, M. Mahdi, S. Peterson, T. Bengtsson, Mona Bafadhel   +12 more
semanticscholar   +1 more source